[HTML][HTML] Usefulness of KL-6 for predicting clinical outcomes in hospitalized COVID-19 patients

M Park, M Hur, H Kim, CH Lee, JH Lee, M Nam - Medicina, 2022 - mdpi.com
Abstract Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial
lung disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.

M Park, M Hur, H Kim, CH Lee, JH Lee… - Medicina (Kaunas …, 2022 - europepmc.org
Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung
disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

[PDF][PDF] Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients

M Park, M Hur, H Kim, CH Lee, JH Lee, M Nam - Medicina, 2022 - academia.edu
Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung
disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients

M Park, M Hur, H Kim, CH Lee… - Medicina (Kaunas …, 2022 - pubmed.ncbi.nlm.nih.gov
Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung
disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

[PDF][PDF] Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients

M Park, M Hur, H Kim, CH Lee, JH Lee… - Medicina, 2022 - pdfs.semanticscholar.org
Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung
disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.

M Park, M Hur, H Kim, CH Lee, JH Lee, M Nam - Medicina, 2022 - go.gale.com
Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung
disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients

M Park, M Hur, H Kim, CH Lee, JH Lee, M Nam - Medicina, 2022 - search.proquest.com
Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung
disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

[HTML][HTML] Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients

M Park, M Hur, H Kim, CH Lee, JH Lee, M Nam - Medicina, 2022 - ncbi.nlm.nih.gov
Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung
disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.

M Park, M Hur, H Kim, CH Lee, JH Lee… - Medicina …, 2022 - search.ebscohost.com
Abstract Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial
lung disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

[引用][C] Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients

M Park, M Hur, H Kim, CH Lee, JH Lee, M Nam - Medicina, 2022 - europepmc.org
Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung
disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …